-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Non-Hodgkin Lymphoma in Children and Adolescents

Program: Education Program
Session: Pediatric Hematological Malignancies: Beyond Acute Lymphocytic Leukemia
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Valencia A (W415A), Level 4 (Orange County Convention Center)
Saturday, December 5, 2015, 2:00 PM-3:30 PM
Tangerine 2 (WF2), Level 2 (Orange County Convention Center)

Rachel Kobos, MD

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Off Label Use: Brentuximab for treatment of newly diagnosed pediatric ALCL Crizotinib for the treatment of newly diagnosed pediatric ALCL Rituximab for the treatment of newly diagnosed pediatric B-cell lymphoma Blinatumomab for the treatment of pediatric B-cell lymphoma .

See more of: Pediatric Hematological Malignancies: Beyond Acute Lymphocytic Leukemia
See more of: Education Program
<< Previous Presentation | Next Presentation